DRKS00024180招募中不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Consenting patients with histologically confirmed non-Hodgkin lymphoma.
排除标准
- •Minors, nursing mothers, pregnant women, patients not capable of giving consent
研究者
相似试验
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
尚未招募
不适用
Circulating tumor DNA as biomarker for perihilar cholangiocarcinomaPerihilar cholangiocarcinoma/ Perihilair cholangiocarcinoomKlatskin-tumorBiomarkerCirculating tumor DNA /Circulerend tumor DNA (ctDNA)NL-OMON27478AMC20
已完成
不适用
Circulating tumor DNA as a biomarker in perihilar cholangiocarcinoma: a feasibility studybiliary tract cancerperihilar cholangiocarcinoma10019815NL-OMON43203Academisch Medisch Centrum20
已完成
不适用
ctDNA as a Biomarker for Treatment Response in HNSCCCarcinoma, Squamous Cell of Head and NeckNCT03540563The Netherlands Cancer Institute70
已完成
不适用
Prospective Evaluation of Circulating Tumour DNA (ctDNA) as Molecular Monitoring Tool and Prognostic Biomarker in Resectable Pancreatic AdenocarcinomasC25Malignant neoplasm of pancreasDRKS00010992niversitätsklinikum Freiburg25